skip navigation

Justinfo Subscribe to Stay Informed

Add your conference to our Justice Events calendar


NCJRS Abstract


Subscribe to Stay Informed
Want to be in the know? JUSTINFO is a biweekly e-newsletter containing information about new publications, events, training, funding opportunities, and Web-based resources available from the NCJRS Federal sponsors. Sign up to get JUSTINFO in your inbox.

The document referenced below is part of the NCJRS Library collection.
To conduct further searches of the collection, visit the NCJRS Abstracts Database.

How to Obtain Documents
NCJ Number: NCJ 202563     Find in a Library
Title: National Synthetic Drugs Action Plan: The Federal Government Response to Production, Trafficking, and Abuse of Synthetic Drugs and Diverted Pharmaceutical Products
  Document URL: PDF 
Corporate Author: Office of National Drug Control Policy
United States of America
Date Published: 10/2004
Page Count: 78
  Annotation: This action plan outlines the Federal Government’s response to the problem of synthetic drugs and diverted pharmaceuticals under the President’s National Drug Control Strategy.
Abstract: In recent years, the production and use of synthetic drugs has grown dramatically. The most significant synthetic drug threat is posed by MDMA and methamphetamine use. Part 1 provides an introduction to the report and identifies the Office of National Drug Control Policy and the Department of Justice as the co-chairs of the new Synthetic Drugs Interagency Working Group (SD-IWG), which will assume overarching responsibility for implementing the recommendations outlined in this report. Recommendations are then provided in the areas of prevention, treatment, regulation, and law enforcement. Part 2 offers an overview of the current consumption and trafficking trends with respect to synthetic drugs and diverted pharmaceuticals in the United States. Part 3 outlines the Federal Government’s plan of action to combat the problem of synthetic drug use and diverted pharmaceutical use. The recommended actions are grouped into the aforementioned categories of prevention, treatment, regulation, and law enforcement action. Current strategies being implemented in these areas are enumerated, followed by recommendations for future action. Recommendations include developing targeted prevention programs, increasing treatment capacity, and enhancing information exchange and coordination with Canada. Appendixes provide information about the proposed outline for an early warning and response system to address emerging drug threats; an overview of the new Drug Abuse Warning Network (DAWN) system; an action plan to prevent the diversion of OxyContin; the regulatory measures that apply to the drugs of interest in this report; and a summary of Missouri and Oklahoma precursor chemical control laws. The SD-IWG must submit a written implementation plan for the recommendations contained herein within 6 months of the publication of this action plan. Figures, appendixes, notes
Main Term(s): Drug Policy
Index Term(s): Governmental planning ; Plans ; MDMA (designer drug)
Sale Source: NCJRS Photocopy Services
Box 6000
Rockville, MD 20849-6000
United States of America

Drug Policy Information Clearinghouse
P.O. Box 6000
Rockville, MD 20849
United States of America
Type: Legislation/Policy Description
Country: United States of America
Language: English
  To cite this abstract, use the following link:

* A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's web site is provided.